EssilorLuxottica, FR0000033219

EssilorLuxottica S.A. stock (FR0000033219): Deutsche Bank initiates Hold rating

13.05.2026 - 16:06:54 | ad-hoc-news.de

Deutsche Bank started coverage on EssilorLuxottica S.A. with a Hold rating and €183 price target, citing AI glasses competition risks. The eyewear giant's shares trade on Euronext Paris.

EssilorLuxottica, FR0000033219
EssilorLuxottica, FR0000033219

Deutsche Bank initiated coverage on EssilorLuxottica S.A. with a "Hold" rating and €183 price target, highlighting competition in AI glasses as a key factor, according to Investing.com as of recent coverage. This comes as the company, a leader in eyewear, navigates tech disruptions in its market.

As of: 13.05.2026

By the editorial team – specialized in equity coverage.

At a glance

  • Name: EssilorLuxottica
  • Sector/industry: Healthcare Equipment & Supplies / Eyewear
  • Headquarters/country: France / Italy
  • Core markets: North America, Europe, Asia-Pacific
  • Key revenue drivers: Prescription lenses, sunglasses, optical frames
  • Home exchange/listing venue: Euronext Paris (ESLX)
  • Trading currency: EUR

Official source

For first-hand information on EssilorLuxottica S.A., visit the company’s official website.

Go to the official website

EssilorLuxottica S.A.: core business model

EssilorLuxottica S.A. operates as a global leader in ophthalmic optics, designing, manufacturing, and distributing lenses, frames, and sunglasses. Formed by the 2018 merger of Essilor and Luxottica, it controls major brands like Ray-Ban, Oakley, and Varilux lenses. The company serves opticians, wholesalers, and retailers worldwide through a vertically integrated model that spans production to retail via chains like LensCrafters and Sunglass Hut. This structure allows control over the supply chain, from lens innovation to branded retail experiences.

For US investors, EssilorLuxottica's extensive North American presence is notable, with significant revenue from the US market where vision care demand grows amid aging populations and screen time increases. The stock lists as an ADR (ESLOF) on US OTC markets, providing accessible exposure to this defensive healthcare play.

Main revenue and product drivers for EssilorLuxottica S.A.

Revenue primarily stems from prescription lenses (about 40%), sunglasses and readers (30%), and equipment/services (20%), per the company's full-year 2024 report published in March 2025 on its investor relations site. Key drivers include premium lens technologies like Transitions photochromic lenses and Varilux progressives, alongside fashion eyewear from luxury partners such as Chanel and Prada. E-commerce and direct-to-consumer channels have grown, boosted by digital vision correction trends.

North America accounts for roughly 40% of sales, making US economic health a direct factor. Recent quarters showed resilient demand despite inflation, with 2024 revenue up 6% at constant exchange rates to €25.8 billion as reported in the annual results.

Industry trends and competitive position

The eyewear industry faces disruption from smart glasses and AI wearables, as noted in Deutsche Bank's initiation. Players like Meta and Google advance AR/VR optics, potentially challenging traditional frames. EssilorLuxottica counters via partnerships, including its Ray-Ban Meta smart glasses launched in 2023, blending fashion with tech. Market data from Statista as of 2025 projects global eyewear sales to reach $190 billion by 2028, driven by emerging markets and premiumization.

Competitively, EssilorLuxottica holds over 20% global share in lenses and 15% in frames, per S&P Global estimates published 2024. Its scale enables R&D investment, with €1.1 billion spent in 2024 on innovations like AI-optimized lens designs.

Why EssilorLuxottica S.A. matters for US investors

US investors gain exposure to a stable consumer staples-like stock with healthcare tailwinds. The OTC ADR (ESLOF) traded around $195-272 USD recently per market data portals, offering currency-hedged access to Euronext Paris (ESLX). Strong US retail footprint via Pearle Vision and Targets' optical departments ties performance to American consumer spending, which remains robust post-2024 recovery.

Conclusion

Deutsche Bank's Hold initiation underscores EssilorLuxottica S.A.'s strengths in eyewear dominance alongside emerging AI competition risks. The company's integrated model and brand portfolio support steady growth, though tech shifts warrant monitoring. Investors track upcoming quarterly results for visibility into smart glasses traction and regional demand.

Read more

Additional news and developments on the stock can be explored via the linked overview pages.

More news on this stockInvestor relations

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.

So schätzen die Börsenprofis EssilorLuxottica Aktien ein!

<b>So schätzen die Börsenprofis EssilorLuxottica Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
FĂĽr. Immer. Kostenlos.
en | FR0000033219 | ESSILORLUXOTTICA | boerse | 69325049 | bgmi